FE ABSORB
A high-bioavailability iron and hematinic support formula designed for the full iron journey: absorption, transport, ferritin restoration, heme synthesis, red blood cell formation, oxygen delivery, methylation and fatigue recovery associated with iron deficiency.
Seven-cofactor hematinic matrix
Designed to support iron absorption, ferritin restoration, red cell maturation, heme synthesis and methylation.
| Ingredient | Strength per tablet | Clinical purpose in formula |
|---|---|---|
| Iron bisglycinate chelate | 45 mg elemental iron | High-bioavailability iron form with better GI tolerability potential than many conventional ferrous salts. Supports ferritin, hemoglobin, myoglobin, cellular oxygen use and erythropoiesis. |
| Vitamin C | 80 mg | Supports non-heme iron solubility and helps maintain iron in a more absorbable reduced state in the intestinal environment. |
| 5-MTHF glucosamine salt | 200 mcg | Active folate support for one-carbon metabolism, DNA synthesis, red blood cell maturation and methylation. |
| Cyanocobalamin | 2.2 mcg | Vitamin B12 support for DNA synthesis, red blood cell formation, methylmalonic acid metabolism and homocysteine remethylation. |
| Copper bisglycinate | 1.2 mg elemental copper | Supports copper-dependent ferroxidase enzymes such as ceruloplasmin and hephaestin, helping mobilize and transport iron. |
| Pyridoxal-5-phosphate | 2 mg | Active vitamin B6 coenzyme support for heme synthesis, amino acid metabolism, transsulfuration and homocysteine handling. |
| Riboflavin-5-phosphate | 2 mg | Active vitamin B2 support for FMN/FAD-dependent energy metabolism, B6 metabolism, methylation support and redox protection. |
One box. One month. One complete pathway.
Use as advised by a healthcare professional, especially in pregnancy, lactation, anemia, chronic disease or medication use.
Once daily course
1 tablet daily for 30 days. Provides 45 mg elemental iron daily. Best for simple compliance and steady hematinic support.
Alternate-day intensive course
2 tablets on alternate days for 30 days. Provides 90 mg elemental iron on dosing days and uses all 30 tablets across 15 dosing days.
Take away from blockers
Keep away from tea, coffee, high-calcium foods, calcium supplements and antacids when possible.
If nausea occurs
Take after a meal. Absorption may be lower with food, but adherence often improves.
Separate medicines
Separate from levothyroxine, tetracycline/quinolone antibiotics, bisphosphonates and other interacting medicines as advised.
Recheck markers
Consider CBC, ferritin, transferrin saturation and TIBC after 30 to 60 days depending on baseline severity.
Designed for usable iron, not just high iron
Horizontal scroll on mobile. Each card frames one reason this formula can outperform basic iron salts in real-world use.
Chelated delivery
Iron bisglycinate supports high bioavailability and better GI tolerance potential compared with many harsh ferrous salts.
Absorption support
Vitamin C helps keep non-heme iron soluble and absorbable in the intestinal environment.
Transport support
Copper supports hephaestin and ceruloplasmin pathways, helping iron move toward transferrin-bound circulation.
Red cell DNA
5-MTHF supports one-carbon metabolism and cell division required during red blood cell maturation.
Maturation coverage
B12 supports healthy red blood cell formation, DNA synthesis, MMA metabolism and homocysteine handling.
Heme initiation
P5P supports ALA synthase biology, the first committed enzymatic step in heme biosynthesis.
Energy link
Riboflavin-5-phosphate supports FMN/FAD-dependent pathways, methylation support and cellular energy metabolism.
| Conventional iron-only approach | FE ABSORB approach | Practical advantage |
|---|---|---|
| Focuses mainly on elemental iron dose. | Combines iron with absorption, transport, heme, red-cell and methylation cofactors. | More complete support for the biological pathway that converts iron into useful red cells. |
| Ferrous salts may cause nausea, constipation and poor continuation. | Uses iron bisglycinate chelate for better GI tolerance potential. | Better adherence potential across the full 30-day course. |
| May ignore copper-linked iron transport. | Includes 1.2 mg elemental copper from copper bisglycinate. | Supports iron export and transferrin-loading biology. |
| May correct hemoglobin while ferritin remains low. | Positions ferritin restoration as a core goal. | Useful in low ferritin with normal hemoglobin, heavy periods and recurrent depletion. |
Composition and ratio synergy
Ratio claims are calculated and clinically framed, avoiding exaggerated or mathematically incorrect positioning.
The Iron-Copper Transfer Axis
45 mg elemental iron + 1.2 mg elemental copper
Iron builds the payload. Copper helps clear the route through copper-linked ferroxidase support.
The Vitamin C Absorption Gate
80 mg vitamin C + 45 mg elemental iron
A physiologic vitamin C support dose designed to assist non-heme iron absorption without turning the product into a megadose vitamin C formula.
The Folate-B12 Maturation Pair
5-MTHF 200 mcg + B12 2.2 mcg
Iron fills the red cell. Folate and B12 help build the red cell correctly through DNA synthesis and maturation support.
The P5P-R5P Heme and Energy Pair
P5P 2 mg + riboflavin-5-phosphate 2 mg
More oxygen matters only when the cell can turn it into energy. This pair connects heme support with mitochondrial and methylation biology.
From gut entry to oxygen delivery
A clear step-by-step pathway for clinicians, sales teams and informed consumers.
Chelated iron delivery
Iron bisglycinate provides a high-bioavailability iron form designed for better GI tolerability.
Vitamin C readiness
Vitamin C supports non-heme iron solubility and a favorable redox environment for uptake.
Enterocyte export
Iron is stored as ferritin or exported via ferroportin; copper-linked hephaestin supports transferrin loading.
Plasma transport
Transferrin carries iron toward marrow erythroblasts for hemoglobin production.
Heme synthesis
P5P supports ALA synthase biology while iron enters the heme structure.
Red cell maturation
5-MTHF and B12 support DNA synthesis, cell division and red blood cell maturation.
| Biological pathway | Formula drivers | Clinical relevance |
|---|---|---|
| DMT1 and intestinal uptake | Iron bisglycinate, vitamin C | Supports iron entry from gut lumen into enterocytes. |
| Ferroportin export | Iron, copper-linked hephaestin | Supports movement of iron from enterocyte into circulation. |
| Transferrin transport | Iron, copper-linked ferroxidase activity | Helps move iron safely through plasma toward marrow. |
| Ferritin restoration | Iron bisglycinate | Supports rebuilding of storage iron, not only hemoglobin. |
| Heme biosynthesis | Iron, P5P | Supports hemoglobin heme formation. |
| Erythropoiesis | Iron, 5-MTHF, B12, P5P | Supports red blood cell production and maturation. |
| Methylation | 5-MTHF, B12, P5P, R5P | Supports homocysteine metabolism and methyl donor cycling. |
| Mitochondrial energy | Iron, R5P, B12 | Supports energy pathways relevant to deficiency-linked fatigue. |
| Redox balance | Vitamin C, copper, R5P, P5P | Supports antioxidant handling during iron repletion. |
Who FE ABSORB is designed for
Primary and secondary use contexts should be guided by lab markers, symptoms and professional judgement.
Iron deficiency anemia
Supports hemoglobin synthesis, red cell production and iron-store restoration in responsive deficiency.
Low ferritin
Especially useful where ferritin is below 30 ng/mL, even if hemoglobin is still near normal.
Heavy menstrual loss
Addresses recurrent iron loss with iron plus red-cell cofactors.
Postpartum depletion
Supports maternal repletion after pregnancy, delivery and blood loss under guidance.
Pregnancy and lactation
Supports higher hematinic demand when advised by an OB/GYN or healthcare professional.
Vegetarian and vegan patterns
Combines iron with vitamin C and B12 support for populations vulnerable to non-heme iron and B12 gaps.
Restless legs with low stores
Relevant when ferritin is low or transferrin saturation is below target after evaluation.
Post-blood donation recovery
Supports rebuilding of hemoglobin iron and storage iron after donation.
Fatigue linked to iron
Supports oxygen delivery and cellular energy pathways when fatigue is related to iron deficiency.
Primary indications
- Lab-confirmed iron deficiency anemia
- Low ferritin below 30 ng/mL
- Iron deficiency without anemia
- Heavy menstrual blood loss with low ferritin or anemia
- Postpartum iron depletion
- Pregnancy-associated increased iron need under supervision
- Lactation-associated nutritional replenishment under guidance
Secondary support contexts
- Fatigue associated with low iron status
- Reduced stamina or exercise tolerance linked to deficiency
- Hair shedding associated with low ferritin
- Brain fog or poor focus associated with iron or B-vitamin insufficiency
- Restless legs symptoms with low ferritin or low transferrin saturation
- Borderline folate/B12 status with iron deficiency pattern
Expected biomarker movement
Scroll through the course timeline. Response varies with baseline severity, adherence, absorption, inflammation and ongoing blood loss.
| Baseline marker | 30-day expected movement with response | Interpretation |
|---|---|---|
| Hb 7-8 g/dL | Possible +0.8 to +2.0 g/dL | Severe anemia range. Requires physician supervision and evaluation for bleeding, pregnancy risk, malabsorption, hemoglobinopathy and need for IV iron or urgent care. |
| Hb 8-9 g/dL | Possible +0.8 to +1.8 g/dL | Moderate anemia. Response should be monitored. |
| Hb 9-10 g/dL | Possible +0.7 to +1.5 g/dL | Typical oral iron response range if deficiency is the main driver. |
| Hb 10-11 g/dL | Possible +0.5 to +1.2 g/dL | Mild anemia, often symptomatic when ferritin is also low. |
| Hb 11-12 g/dL | Possible +0.3 to +1.0 g/dL | May reflect early deficiency, pregnancy physiology or low stores with near-normal Hb. |
| Ferritin below 10 ng/mL | Possible +8 to +20 ng/mL | Deep store depletion. Symptoms may improve before stores are fully repleted. |
| Ferritin 10-20 ng/mL | Possible +10 to +25 ng/mL | Good target group for 30-day improvement. |
| Ferritin 20-30 ng/mL | Possible +10 to +20 ng/mL | Low stores even if Hb is normal. |
| Ferritin 30-50 ng/mL | Possible +5 to +15 ng/mL | Useful in selected symptomatic patients, athletes, heavy menstrual bleeding, pregnancy demand or RLS context under guidance. |
| Transferrin saturation below 20% | Expected upward movement | Supports improved circulating iron availability. |
| MCV/MCH low | Gradual normalization | Red cell indices lag because older microcytic cells remain in circulation. |
| Homocysteine high | May decrease if related to B-vitamin insufficiency | Functional methylation marker, not a disease claim. |
| MMA high | May decrease if related to B12 insufficiency | MMA is more specific to B12 status but can rise with renal impairment. |
Built around real iron demand patterns
Scroll horizontally on mobile. Each card is ready to use for brochure, website or doctor-facing communication.
Pregnancy
Supports expanding blood volume, ferritin reserve, hemoglobin formation and hematinic cofactor demand under OB/GYN guidance. Not a complete prenatal replacement.
Pre-natal planning
Build the reserve before the demand begins. Low ferritin entering pregnancy can become more symptomatic as demand rises.
Lactation
Postpartum is not just recovery. It is repletion. FE ABSORB supports maternal replenishment when stores are depleted after pregnancy and delivery.
Heavy menstruation
When blood loss is monthly, iron support must be complete. Supports ferritin, hemoglobin and red-cell rebuilding in women with recurrent losses.
Menopause
After menopause, iron should be measured before it is supplemented. Confirmed deficiency should prompt evaluation for GI loss, malabsorption or chronic disease.
Where synergy matters most
Expandable evidence-style blocks keep the page distraction free while preserving clinical depth.
Low ferritin with normal hemoglobin
Vegetarian and vegan deficiency patterns
Heavy menstrual loss and recurring depletion
Restless legs with low ferritin
Post-blood donation recovery
Poor GI tolerance to iron salts
PPI use, low gastric acidity or absorption barriers
Contraindications, cautions and referral triggers
Clear safety framing protects the consumer, clinician, distributor and brand.
Do not use without medical guidance in
- Hereditary hemochromatosis or known iron overload
- Hemosiderosis or repeated transfusions unless prescribed
- Hemolytic anemia or anemia not caused by iron deficiency
- Thalassemia major/intermedia unless iron deficiency is confirmed
- Chronic liver disease, chronic kidney disease anemia or active severe inflammatory disease
- Children, unless advised by a pediatric professional
Use with separation or professional advice if taking
- Levothyroxine
- Tetracycline or quinolone antibiotics
- Bisphosphonates
- Levodopa or methyldopa
- Calcium supplements, antacids, PPIs or high-calcium meals around dose time
Catchy, clinically balanced lines
Use these lines for banners, cards, sales decks, WhatsApp creatives and short page modules.
Short sales pitch
FE ABSORB is not a conventional iron tablet. It is a complete hematinic support system built with iron bisglycinate, vitamin C, active folate, B12, copper, P5P and riboflavin-5-phosphate. This combination supports the full iron pathway: gut absorption, transferrin transport, ferritin restoration, heme synthesis, red blood cell maturation, methylation and energy recovery. With 30 tablets in a complete 30-day course, FE ABSORB is designed for people with low ferritin, iron deficiency, heavy menstrual loss, postpartum depletion, vegetarian iron vulnerability, pregnancy/lactation demand under guidance and fatigue related to low iron status.
FE ABSORB: Ferritin first. Hemoglobin next. Energy follows.
Source-friendly clinical framing
Links open the reference sources used to support the scientific and compliance positioning.
For indication fit, franchise or purchase
Partner for a differentiated hematinic supplement with strong clinical positioning, high-bioavailability iron, women-focused use cases and a complete 30-day course format.
Label and compliance language: This product is not intended to diagnose, treat, cure or prevent any disease. Dietary supplements should not be used as a substitute for a varied diet. Use during pregnancy, lactation, anemia, chronic illness or medication use should be under healthcare professional supervision. Do not exceed recommended usage. Keep out of reach of children. Store in a cool, dry place away from direct sunlight.
Iron warning: Accidental overdose of iron-containing products can be dangerous in children. Keep tightly closed and out of reach of children.